Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Feb 7, 2013; 19(5): 721-726
Published online Feb 7, 2013. doi: 10.3748/wjg.v19.i5.721
Published online Feb 7, 2013. doi: 10.3748/wjg.v19.i5.721
Australian tertiary care outcomes of entecavir monotherapy in treatment naive patients with chronic hepatitis B
Farzan Fahrtash-Bahin, Viraj C Kariyawasam, Jacob George, Mark W Douglas, Storr Liver Unit, Westmead Millennium Institute, University of Sydney at Westmead Hospital, 2145 Sydney, Australia
Karen Byth, Department of Biostatistics, School of Public Health, University of Sydney, 2145 Sydney, Australia
Timothy Gray, Mark W Douglas, Centre for Infectious Diseases and Microbiology and Sydney Emerging Infections and Biosecurity Institute, University of Sydney at Westmead Hospital, 2145 Sydney, Australia
Author contributions: Fahrtash-Bahin F collected data, analyzed data and wrote up manuscript; Kariyawasam VC collected data, analyzed data and wrote up manuscript; Gray T planned study, collected data and reviewed manuscript; Byth K analyzed data; George J planned study and reviewed manuscript; Douglas MW planned study, supervised data collection and analysis and revised manuscript.
Correspondence to: Mark W Douglas, MBBS, PhD, FRACP, Storr Liver Unit, Westmead Millennium Institute, University of Sydney at Westmead Hospital, PO Box 412, Westmead, 2145 Sydney, Australia. mark.douglas@sydney.edu.au
Telephone: +61-2-98457705 Fax: +61-2-96357582
Received: August 25, 2012
Revised: October 25, 2012
Accepted: November 14, 2012
Published online: February 7, 2013
Processing time: 164 Days and 15.9 Hours
Revised: October 25, 2012
Accepted: November 14, 2012
Published online: February 7, 2013
Processing time: 164 Days and 15.9 Hours
Core Tip